CVE-2024-21410
Published: February 15, 2024
Official Description
Microsoft Exchange Server contains an unspecified vulnerability that allows for privilege escalation.
CISA KEV Advisory
Microsoft Exchange Server Privilege Escalation Vulnerability
Microsoft Exchange Server contains an unspecified vulnerability that allows for privilege escalation.
Apply mitigations per vendor instructions or discontinue use of the product if mitigations are unavailable.
Risk Analysis
This high-severity vulnerability in Microsoft Exchange Server allows for privilege escalation. Its inclusion in CISA's KEV catalog and an EPSS score of 0.03150 highlight that this is a confirmed and actively exploited issue. Successful exploitation could grant an attacker higher-level access within the Exchange environment.
This vulnerability is actively being exploited in the wild, as indicated by its presence in CISA's KEV catalog. The specific exploitation vector is not detailed, but it leads to privilege escalation.
Administrators should prioritize applying all available security updates and patches for Microsoft Exchange Server. Regular security audits and principle of least privilege should also be enforced.
Technical Analysis
CVE-2024-21410 requires local access, meaning attackers must already have a foothold on the target system.
Exploitation requires some privileges, which limits the exposure to scenarios where an attacker has already gained initial access.
CISA has added CVE-2024-21410 to the Known Exploited Vulnerabilities (KEV) catalog, confirming active exploitation in the wild. U.S. federal agencies are required to patch this within the mandated timeframe, and all organizations should treat remediation as urgent.
Affected Vendors & Products
Exploit & PoC Resources
All References (2)
Quick Facts
Recommended Actions
- →Apply vendor patches immediately
- →Monitor CVE-2024-21410 in threat intel feeds
- →Review IDS/IPS signatures for exploitation attempts
- !CISA KEV: Federal agencies must patch per BOD 22-01 timeline
- !Active exploitation confirmed — treat as P1